Clinical trials for Malignant peripheral nerve sheath tumor
5 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGEarly Phase 1NCT06693284A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]University of Minnesota · PI: Robert Galvin, MD
- RECRUITINGPhase 2NCT04872543A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)Memorial Sloan Kettering Cancer Center · PI: Ping Chi, MD, PhD
- RECRUITINGPhase 1NCT04222413Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsNational Cancer Institute (NCI) · PI: Udo Rudloff, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT03872427Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN StudyNational Cancer Institute (NCI) · PI: Funda Meric-Bernstam
- RECRUITINGN/ANCT03141021Multi-Institutional Registry for Malignant Peripheral Nerve Sheath TumorsWashington University School of Medicine · PI: Angela Hirbe, M.D., Ph.D.